Ayşe Kars

1.1k total citations
73 papers, 773 citations indexed

About

Ayşe Kars is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Ayşe Kars has authored 73 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 26 papers in Pulmonary and Respiratory Medicine and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Ayşe Kars's work include Lymphoma Diagnosis and Treatment (19 papers), Sarcoma Diagnosis and Treatment (10 papers) and Viral-associated cancers and disorders (9 papers). Ayşe Kars is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Sarcoma Diagnosis and Treatment (10 papers) and Viral-associated cancers and disorders (9 papers). Ayşe Kars collaborates with scholars based in Türkiye, Palestinian Territory and India. Ayşe Kars's co-authors include Nurşen Başaran, Gülten Tekuzman, Dicle Güç, İbrahim Barışta, Emin Kansu, İ. Çelik, D. Fırat, Ülkü Ündeğer, Alev Türker and Hande Canpınar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ayşe Kars

70 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayşe Kars Türkiye 16 254 187 162 132 90 73 773
Britta Mattsson Sweden 9 387 1.5× 170 0.9× 155 1.0× 136 1.0× 90 1.0× 12 934
Gerald Langman United Kingdom 15 369 1.5× 157 0.8× 135 0.8× 137 1.0× 95 1.1× 48 918
C. Bokemeyer Germany 16 268 1.1× 299 1.6× 121 0.7× 75 0.6× 171 1.9× 68 828
Jocelyne Flament United States 17 228 0.9× 91 0.5× 327 2.0× 47 0.4× 100 1.1× 31 955
Herbert Stöger Austria 19 562 2.2× 259 1.4× 156 1.0× 158 1.2× 165 1.8× 68 1.1k
Alain Monnereau France 14 306 1.2× 116 0.6× 278 1.7× 84 0.6× 109 1.2× 42 868
Ami V. Desai United States 18 250 1.0× 229 1.2× 111 0.7× 195 1.5× 278 3.1× 52 1.0k
Hung Chang Taiwan 18 252 1.0× 144 0.8× 254 1.6× 65 0.5× 217 2.4× 98 1.0k
Jennifer Herring United States 11 347 1.4× 175 0.9× 81 0.5× 41 0.3× 180 2.0× 21 788
Fang Cheng China 18 182 0.7× 162 0.9× 117 0.7× 61 0.5× 152 1.7× 59 789

Countries citing papers authored by Ayşe Kars

Since Specialization
Citations

This map shows the geographic impact of Ayşe Kars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayşe Kars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayşe Kars more than expected).

Fields of papers citing papers by Ayşe Kars

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayşe Kars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayşe Kars. The network helps show where Ayşe Kars may publish in the future.

Co-authorship network of co-authors of Ayşe Kars

This figure shows the co-authorship network connecting the top 25 collaborators of Ayşe Kars. A scholar is included among the top collaborators of Ayşe Kars based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayşe Kars. Ayşe Kars is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nemutlu, Emirhan, Tuba Reçber, Cemil Can Eylem, et al.. (2022). Liquid biopsy markers for early diagnosis of brain metastasis patients with breast cancer by metabolomics. European Journal of Mass Spectrometry. 28(1-2). 56–64. 9 indexed citations
2.
3.
Akın, Serkan, et al.. (2018). Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma. Current Problems in Cancer. 42(3). 344–349. 8 indexed citations
4.
Kılıçkap, Saadettin, İbrahim Barışta, İ. Çelik, et al.. (2012). Clinical Features and Prognostic Factors of Hodgkin’s Lymphoma: A Single Center Experience. Balkan Medical Journal. 30(2). 178–185. 11 indexed citations
5.
Gürel, Bora, et al.. (2009). Langerhans' cell histiocytosis mimicking metastatic carcinoma of the lung. Respirology. 14(3). 456–458. 2 indexed citations
6.
Kılıçkap, Saadettin, Ayşe Kars, Erhan Hamaloğlu, & Cem Şimşek. (2009). A case of recurrent metastatic hepatocellular cancer controlled with immunotherapy and antiviral therapy following resection. Medical Oncology. 26(4). 501–505. 2 indexed citations
7.
8.
Dızdar, Ömer, Mustafa Erman, Mustafa Cankurtaran, et al.. (2007). Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significance. Annals of Hematology. 87(1). 57–60. 7 indexed citations
9.
Oyan, Başak, Yener Koç, Ayşe Kars, et al.. (2005). IIVP Salvage Regimen Induces High Response Rates in Patients With Relapsed Lymphoma Before Autologous Stem Cell Transplantation. American Journal of Clinical Oncology. 28(3). 264–269. 6 indexed citations
10.
11.
Koç, Yener, Başak Oyan, Ayşe Kars, et al.. (2004). A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia. Hematological Oncology. 22(2). 43–53. 4 indexed citations
12.
Başaran, Nurşen, et al.. (2002). Alterations in immune parameters in foundry and pottery workers. Toxicology. 178(2). 81–88. 15 indexed citations
13.
Barışta, İbrahim, Ayşe Kars, Şevket Ruacan, et al.. (2000). Primary Breast Lymphomas: A Retrospective Analysis of Twelve Cases. Acta Oncologica. 39(2). 135–139. 34 indexed citations
14.
Akova, Murat, Hamdi Akan, Volkan Korten, et al.. (1999). Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. International Journal of Antimicrobial Agents. 13(1). 15–19. 29 indexed citations
15.
Zengin, Nurullah, Ayşe Kars, Yavuz Özışık, et al.. (1998). Aleukemic leukemia cutis in a patient with acute lymphoblastic leukemia. Journal of the American Academy of Dermatology. 38(4). 620–621. 15 indexed citations
16.
Kiraz, Sedat, İbrahim Barışta, İ. Çelik, et al.. (1996). Ifosfamide, Mesna and Epirubicin as Second-Line Chemotherapy in Advanced Breast Cancer. Journal of Chemotherapy. 8(4). 310–314. 5 indexed citations
17.
Güllü, İbrahim, İ. Çelik, Gülten Tekuzman, et al.. (1996). Procarbazine, Ccnu, Vincristine Combination in the Treatment of Brain Tumors. Tumori Journal. 82(3). 228–231. 3 indexed citations
18.
Güllü, İbrahim, Şuayib Yalçın, Gülten Tekuzman, et al.. (1996). High-Dose Ifosfamide by Infusion with Mesna in Advanced Refractory Sarcomas. Cancer Investigation. 14(3). 239–242. 8 indexed citations
19.
Beneklı, Mustafa, İbrahim Güllü, Abdurrahman Kadayıfçı, et al.. (1995). Tumor Lysis Syndrome Following Single-Dose Mitoxantrone. Chemotherapy. 41(6). 470–472. 7 indexed citations
20.
Barışta, İbrahim, Gülten Tekuzman, D. Fırat, et al.. (1994). Non‐Hodgkin's Lymphomas in Turkey: Eighteen Years’Experience at the Hacettepe University. Japanese Journal of Cancer Research. 85(12). 1200–1207. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Britta Mattsson Breakdown of academic impact, for papers by Gerald Langman Breakdown of academic impact, for papers by C. Bokemeyer Breakdown of academic impact, for papers by Jocelyne Flament Breakdown of academic impact, for papers by Herbert Stöger Breakdown of academic impact, for papers by Alain Monnereau Breakdown of academic impact, for papers by Ami V. Desai Breakdown of academic impact, for papers by Hung Chang Breakdown of academic impact, for papers by Jennifer Herring Breakdown of academic impact, for papers by Fang Cheng
Rankless by CCL
2026